Arita K, Uozumi T, Oki S, Ohtani M, Taguchi H, Morio M
Department of Neurosurgery, Hiroshima University School of Medicine, Japan.
No Shinkei Geka. 1988 Sep;16(10):1163-71.
According to the report of the Health and Welfare Ministry's research committee on brain death (1985), "brain death is defined as an irreversible cessation of the total brain function including brain stem." However, in brain death patients, whether the hypothalamic function which belongs to the brain stem function has completely ceased or not is unknown. In order to evaluate the hypothalamic function in brain death patients, the blood levels of the pituitary hormones and hypothalamic hormones were measured, and anterior pituitary stimulation test with triple bolus injection (TRH 500 micrograms, LH-RH 100 micrograms, regular insulin 0.3-0.7 unit/kg) was performed. The subjects were 13 brain death patients whose clinical states fully satisfied the criteria proposed by the committee. 1) The average blood levels of anterior pituitary hormones in these brain death patients were within normal range, and that of growth hormone was more than the twice of the normal level. 2) The blood anterior pituitary hormones were detectable in almost all cases even several days after the diagnosis of the brain death. 3) LH reserve was maintained in three cases. FSH reserve was maintained in three cases. Prolactin reserve was maintained in two cases. TSH reserve was maintained in one case. 4) Blood ADH (antidiuretic hormones) were detectable in 7 cases out of 9 cases. The blood ADH level of one case, in particular, was rather high (above 10 pg/ml). 5) Histopathologically anterior pituitaries were examined in three autopsy cases. The central necrotic areas were observed in all cases, but normal pituitary tissues existed peripherally. And all anterior pituitary hormones could be recognized immunohistochemically. 6) The blood levels of the hypothalamic hormones (GRF, CRF, LH-RH) were measured in four cases. The hypothalamic hormones were detectable in all cases. In one case, the levels of GRF were within normal range even 9 or 15 days after the diagnosis of brain death.(ABSTRACT TRUNCATED AT 250 WORDS)
根据厚生省脑死亡研究委员会1985年的报告,“脑死亡被定义为包括脑干在内的全脑功能不可逆性停止”。然而,脑死亡患者中,属于脑干功能的下丘脑功能是否已完全停止尚不清楚。为评估脑死亡患者的下丘脑功能,测定了垂体激素和下丘脑激素的血药浓度,并进行了三联推注前垂体刺激试验(促甲状腺激素释放激素500微克、促黄体生成素释放激素100微克、正规胰岛素0.3 - 0.7单位/千克)。研究对象为13例临床状态完全符合该委员会提出标准的脑死亡患者。1)这些脑死亡患者垂体前叶激素的平均血药浓度在正常范围内,生长激素的血药浓度超过正常水平的两倍。2)几乎所有病例在脑死亡诊断后数天仍可检测到血垂体前叶激素。3)3例患者维持了促黄体生成素储备。3例患者维持了促卵泡生成素储备。2例患者维持了催乳素储备。1例患者维持了促甲状腺激素储备。4)9例患者中有7例可检测到血抗利尿激素(抗利尿激素)。特别是1例患者的血抗利尿激素水平相当高(超过10皮克/毫升)。5)对3例尸检病例的垂体前叶进行了组织病理学检查。所有病例均观察到中央坏死区,但周边存在正常垂体组织。并且所有垂体前叶激素均可通过免疫组织化学方法识别。6)对4例患者测定了下丘脑激素(生长激素释放因子、促肾上腺皮质激素释放因子、促黄体生成素释放激素)的血药浓度。所有病例均可检测到下丘脑激素。1例患者在脑死亡诊断后9天或15天,生长激素释放因子水平仍在正常范围内。(摘要截选至250字)